This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The study is expected to be the world’s first Phase 2a clinicaltrial evaluating the efficacy of psilocybin and psychotherapy to treat fibromyalgia. The open-label Phase 2a clinicaltrial will evaluate the efficacy of TRYP-8802, an oral formulation of synthetic psilocybin, in tandem with psychotherapy for treating fibromyalgia.
Many patients are turning to cannabis for insomnia relief, seeking its potential to improve sleep quality and duration. Insomnia is a common sleep disorder characterized by difficulty falling asleep, staying asleep, or experiencing non-restorative sleep despite having the opportunity to sleep.
IGC”) (NYSE American: IGC) announces today that it has completed Cohort 2 of its Phase 1 clinicaltrial on IGC’s tetrahydrocannabinol (“THC”)-based investigational new drug, IGC-AD1, intended to alleviate the symptoms of individuals suffering from Alzheimer’s disease. This Phase 1 trial is currently testing IGC-AD1 for safety.
Cannabis oil is being used successfully in combination with chemotherapy and radiation to kill cancer but also to help unwanted side effects such as nausea, loss of appetite, sleep disturbances, depression, anxiety, and pain. Of 272 combined patients, 86% experienced some clinical benefit, and 10% experienced a complete clinical response.
Instead, patients turn to a mix of whatever individual medications, therapies, and lifestyle changes (especially exercise) help ease symptoms and improve quality of life. No single drug yet exists to address all of the disease’s effects on the body, which can include widespread aches and pains, sleeplessness, fatigue, anxiety, and depression.
Post-Traumatic Stress Disorder (PTSD) is a multifaceted mental health condition triggered by experiencing or witnessing traumatic events, persistently manifesting in symptoms like flashbacks, severe anxiety, and disrupted sleep. Research suggests that cannabinoids may modulate these processes, potentially offering relief from PTSD symptoms.
A new review published by scientific journal, Pharmacology Biochemistry and Behavior , has found that marijuana cannabinoid, CBD, is a “promising” therapy for treating cocaine dependence. Exploring alternative therapies, researchers turned their attention to marijuana cannabinoid, cannabidiol – more commonly referred to as CBD.
Then I saw someone with Stage 4 breast cancer end up in remission from cannabis-based therapy, someone else with skin cancer; kid after kid with seizures all being treated. Tindall also hope to commence the clinicaltrials with Vanuatu for diabetes treatment. There seemed so much more to it.”.
Their position as therapeutic practitioners, as well as their work in conducting the kind of clinicaltrials necessary to advance regulatory outcomes for psychedelic medicines, make them ideal partners in alignment with Optimi’s strategic goals.”. VANCOUVER, British Columbia, July 13, 2022 (GLOBE NEWSWIRE) — Optimi Health Corp. (
Of those states that had legalized medical marijuana, 14 currently consider Parkinson’s disease a qualifying condition for medical marijuana therapies. The most common non-motor symptoms that cannabis users were trying to treat with their cannabis use were anxiety, pain, and sleep disorders. Florida is among these states.
The Company and Its Subsidiary KGK Science Have Also Completed the Pre-Qualification Audits of Its Canadian Facilities to Enable ClinicalTrials in an Arrangement with Aleafia Health. The audits will enable KGK to conduct clinicaltrials in the areas of psychedelics and nutraceuticals, among other substances of study.
Disease-modifying therapies (DMTs) are essential in altering the immune response to reduce inflammation and prevent further damage to the nervous system. Additionally, no current treatments can reverse existing neurological damage, highlighting the need for ongoing research into more effective therapies and potential cures.
Natural plant therapy , and cannabis specifically, has been studied for its effectiveness in alleviating and treating many of these physiological and emotional symptoms that come into play with a terminal illness. One study from the Journal of Clinical Oncology examined the efficacy of cannabinoids in appetite stimulation.
According to CAMH’s lead investigator, clinicaltrials suggest that psilocybin, combined with psychotherapy, can produce “ sustained antidepressant effects” in individuals living with severe depression.
A combined therapy of opiates and cannabis could result in reduced opiate dosages. Research Shows Three puffs a day of cannabis, better known as marijuana, helps people with chronic nerve pain due to injury or surgery feel less pain and sleep better, a Canadian team has found.
Cannabis oil is being used successfully in combination with chemotherapy and radiation to kill cancer but also to help unwanted side effects such as nausea, loss of appetite, sleep disturbances, depression, anxiety, and pain. Of 272 combined patients, 86% experienced some clinical benefit, and 10% experienced a complete clinical response.
A 2020 study reported that the top conditions reported amongst veterans include chronic pain , sleep problems , anxiety , and depression. The study reported that cannabis was associated with a reduction in PTSD-related nightmares as well as contributing to improved sleep. What Is The Latest Research for Veterans and PTSD?
This is despite a limited number of high-quality clinicaltrials investigating the drug’s efficacy for this condition. Using data from the Therapeutic Goods Administration (TGA) – Australia’s Special Access Scheme B, the researchers found the other two top reasons for prescriptions were pain and sleep disorders.
Use of CBD in seizure prevention is well-documented with research ; and now, after conducting its own trials, the FDA appears to agree. Epidiolex’s effectiveness was studied in three randomized, double-blind, placebo-controlled clinicaltrials involving 516 patients with either Lennox-Gastaut syndrome or Dravet syndrome.
Clinicaltrials and studies are underway to examine the potential benefits and risks of MMJ as a treatment option for epilepsy. Improved Quality of Life: Many patients report an overall improvement in their well-being, including enhanced mood, better sleep, and increased energy.
The study is titled A pediatric patient with autism spectrum disorder and epilepsy using cannabinoid extract as complementary therapy: A case report. Further research is needed to elucidate the clinical role and underlying biological mechanisms of action of cannabidiol-based extract in patients with autism spectrum disorder.
cbdMD began its first phase of research in the Fall of 2020, with its first in vivo animal study and clinicaltrials. The second phase of research is now underway to identify promising cannabinoids for both human and pet drug therapies.
Cannabis for Insomnia: Understanding Its Sleep-Inducing Properties Insomnia is a common sleep disorder that can significantly impact daily functioning and overall well-being. Medical marijuana, especially strains with high levels of the terpene myrcene and sedating indica varieties, has shown promise in promoting sleep.
The first method involves therapy, which may include exposing oneself to the subjects of obsession or compulsion while trying to mitigate negative responses. In some cases, people may use pharmaceutical medications in addition to therapy. Soothing headaches in addition to other discomforts like abdominal pains caused by their medicine.
the components of the cannabis plant (phytocannabinoids, terpenes, and flavonoids) and the health effects of cannabinoid-based therapy in the various patient populations. Who monitors their health and the long-term effects of the marijuana therapy?
Insomnia Relief: Many individuals struggling with insomnia have reported improved sleep quality and duration when using cannabinoids, particularly CBD, which can promote relaxation and better sleep patterns. CBD’s anti-seizure properties, demonstrated through clinicaltrials, have made it a game-changer in the epilepsy field.
Traditional treatments, such as medications and physical therapy, usually fall short of providing effective relief. Combine with Other Treatments: Use medical marijuana together with other pain relief strategies, such as medications, physical therapy, and lifestyle changes, to enhance overall pain management.
What are the common adverse events noted in clinicaltrials examining the efficacy of cannabinoids for ASD? These adverse events were similar the adverse events in the trials examining the efficacy of CBD for the treatment of seizures.
The ECS plays an important role in managing numerous processes, ranging from sleep, mood, immune functions, metabolism, movement and pain. Unfortunately, the amount and type of cannabis the patients in this survey used for therapy is unknown.
For years, Tim Gresh took dozens of prescription opioid medications per day, seeking any relief for the debilitating back pain that he – no matter which medication or therapy he used – could just not shake. . “It The researchers stressed the need for large, well-designed clinicaltrials.
This shift towards cannabis-based therapies is reshaping the landscape of Crohn’s management, offering new hope and improved quality of life for patients who have long struggled with the disease’s debilitating symptoms. Some clinicaltrials have focused on the anti-inflammatory effects of cannabis in Crohn’s disease.
What most people don’t understand is that CBD may be helpful for symptom management for conditions such as anxiety, inflammation, pain, sleep and certain types of seizures, however, figuring out how to achieve those effects is a bit more complicated. She educates people on CBD and cannabis as a complementary and alternative therapy. .
While discussing cannabinoid therapy with my patients, I often share that we’re not just treating chorea or sleep disturbances we’re preserving moments. Through carefully tailored cannabinoid therapy, we didn’t just manage her motor symptoms we helped her preserve her cultural identity and family role.
Furthermore, ongoing clinicaltrials are investigating CBD’s efficacy in treating conditions such as multiple sclerosis, Parkinson’s disease, and substance abuse disorders. Sleep disturbances are prevalent among individuals of all ages and can have a profound impact on overall health and well-being.
As yet there have been no FDA -approved clinicaltrials to determine the efficacy of CBD -rich cannabis oil extracts for traumatic brain injury. government-sponsored scientific research – and to extensive anecdotal accounts from medical marijuana patients – which highlight the potential of cannabinoid-based therapies for TBI.
Clinical research: Today many scientists are researching the medicinal value of these mushrooms. The results are so compelling that the FDA has categorized magic mushrooms as a “breakthrough therapy” for depression, and is committed to fast tracking its approval. As such, there have been numerous clinicaltrials using ketamine.
For instance when it comes to pain relief, THC and CBD have shown to be safer than opioids; and for anti-anxiety and sleep aids, CBD does not appear to be habit-forming like benzodiazepines. Getting a good night’s sleep is a crucial step in leading a healthier lifestyle, and the benefits can be felt throughout the day. A healthy diet.
Cannabinoids (natural and plant-derived) interact with endocannabinoid receptors to regulate appetite, sleep, pain, stress, and more. Prior to receiving FDA approval, Epidiolex underwent a number of clinicaltrials establishing the medical efficacy of CBD. Researchers believe cannabis contains over 100 unique chemical compounds!
After several trials with traditional forms of therapy and medication with no long-term effectiveness, researchers decided to give CBD oil a shot. To their surprise, the patient was able to have long-term, sustained results of lower levels anxiety as well as better and longer sleep.
The drug candidate platform is for the treatment of symptoms related to Tourette syndrome (TS), as well as obstructive sleep apnea (OSA) and chronic pain. Cannabis oil: TO Pharmaceuticals TO Pharma is developing next-generation cannabinoid therapies for debilitating diseases. Research programme: cannabidiol-combination therapies.
In recent years, there has been growing interest in exploring alternative therapies for individuals with ASD. The ECS plays a crucial role in regulating various physiological processes, including mood, pain sensation, sleep, and immune function. One such area of focus is the use of CBD-rich cannabis.
While antiretroviral therapy (ART) has transformed HIV/AIDS from a fatal diagnosis to a manageable chronic condition, patients often endure chronic pain, nausea, appetite loss, and psychological distress. Besides, its natural origin appeals to patients seeking alternative or complementary therapies.
Crohn’s ), chronic pain , appetite loss , issues with sleep , immune system disorders , thermoregulation problems, cancer and more. While there have been significant studies done over the years, only chronic pain, antiemesis, multiple sclerosis , and sleep have any level of evidence of cannabis effectiveness.
The effects were so promising that Parkinson’s UK began funding for the worlds first clinicaltrial. This trial would be used to assess whether or not CBD could treat the psychosis symptoms of Parkinson’s. This trial was to take 3.5 However, they also stated that there have been promising effects noted in lab studies.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content